Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07174440 · ClinicalTrials.gov registry record · NA
Contrast and Anesthetic Level With Lumbar Erector Spinae Plan (ESP) Block
A NA study of Pain, sponsored by University Hospitals Cleveland Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT07174440: Recruiting NA study of Pain, sponsored by University Hospitals Cleveland Medical Center.
NCT07174440 is a NA study of Pain that is actively recruiting participants, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 32 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07174440, a NA study of Pain, is actively recruiting participants, sponsored by University Hospitals Cleveland Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
As per usual care for spine surgery, participants will have their back cleaned with alcohol and a needle will be placed using ultrasound for the ESP block. Through the needle, a small catheter will be placed in the participants back and the needle removed. Approximately one hour prior to the start of surgery, a numbing medication (ropivacaine, similar to Novocaine) in combination with dexmedetomidine (a pain medicine that is used in nerve block and that is not a narcotic) and contrast dye (iohexol) will be injected through the catheter. Participants will then go through the QST procedure (test of buzzing sensation and temperature sensation through pads applied to their skin) to assess the numb areas and then head to the operating room. In the operating room, the catheter will be removed after the surgeon obtains baseline CT scan images of the spine. Once surgery is completed, investigators will record pain scores over the next four days in the hospital and the amount of pain medication needed for controlling pain related to the surgery.
Primary Outcome
NRS rates pain intensity on a scale of 0 to 10, with 0 being no pain and 10 being worst possible pain.
Conditions Studied
Interventions
- DRUG Dexmedetomidine
- DRUG Iohexol
- DRUG Ropivacaine (Epidural analgesia)
- PROCEDURE QST Procedure
Study Locations (1)
Ohio
- University Hospitals Cleveland Medical Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2025-09-15 |
| Est. Completion | 2027-01-25 |
| Phase | NA |
What NCT07174440 shows while recruiting
NCT07174440 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 4 interventions - of which Dexmedetomidine is the first listed.
NCT07174440 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT07174440 about?
NCT07174440 is a clinical study titled "Contrast and Anesthetic Level With Lumbar Erector Spinae Plan (ESP) Block". As per usual care for spine surgery, participants will have their back cleaned with alcohol and a needle will be placed using ultrasound for the ESP block. Through the needle, a small catheter will be placed in the participants back and the needle removed. Approximately one hour prior to the start o...
What is the current status of trial NCT07174440?
This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2025-09-15. Estimated completion is 2027-01-25.
What conditions does trial NCT07174440 study?
This clinical trial studies the following conditions: Pain.
What interventions are being tested in trial NCT07174440?
The interventions under investigation include: Dexmedetomidine (DRUG), Iohexol (DRUG), Ropivacaine (Epidural analgesia) (DRUG), QST Procedure (PROCEDURE).
Who is sponsoring clinical trial NCT07174440?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07174440 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07174440's enrollment target sits among peer trials
32 307th of 374 higher than 66 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Pain With Dementia
RECRUITING · NA
-
Oklahoma Study of Native American Pain Risk IV: Smoking Cessation and Pain
RECRUITING · NA
-
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI